APO-GABAPENTIN
APOTEX INC
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of APO-GABAPENTIN in Canada?
Yes. APO-GABAPENTIN 100MG has an active shortage reported to Health Canada (last updated November 12, 2026).
Why is APO-GABAPENTIN not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will APO-GABAPENTIN be available again?
The manufacturer's estimated resolution date is December 11, 2026. This is an estimate and can change; follow this page to get an email when the status changes.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
TEVA-GABAPENTIN
TEVA CANADA LIMITED
RIVA-GABAPENTIN
LABORATOIRE RIVA INC.
Other Products
PMS-GABAPENTIN
PHARMASCIENCE INC
GABAPENTIN
SIVEM PHARMACEUTICALS ULC
AURO-GABAPENTIN
AURO PHARMA INC
AURO-GABAPENTIN TABLETS
AURO PHARMA INC
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
DIN
02244304
Strength
100MG
Dosage Form
CAPSULE
Route
ORAL
Compare with another product →
Shortage Timeline
Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.
Shortage History
Disruption of the manufacture of the drug.
Disruption of the manufacture of the drug.
Disruption of the manufacture of the drug.
Disruption of the manufacture of the drug.
Other Products from APOTEX INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
50MCG · DIN 02460513
325MG · DIN 02362341
500MG · DIN 02362368
DIN 02290901
325MG · DIN 02362422
500MG · DIN 02362244
10MG · DIN 02240414
20MG · DIN 02296098
150MG · DIN 02296160
75MG · DIN 02230507
2MG · DIN 02554178
2MG · DIN 02554194